NCT05554315

Brief Summary

Background: Blood pressure is one of the key markers of cardiovascular health. High blood pressure, also called hypertension, can increase the risk of heart disease or stroke. Monitoring a person s blood pressure continuously over a 24-hour period at home is the best way to diagnose hypertension, but the equipment currently used to do it is cumbersome. This natural history study will test a new technique for monitoring blood pressure continuously over time. Objective: To test a new technique (speckle plethysmography) for measuring blood pressure in healthy adults. Eligibility: Healthy people aged 18 years and older. Design: Participants will come to the clinic a minimum of 2 times. The screening visit will last up to 2 hours. Participants will have a physical exam. Their vital signs will be taken. The clinical visit will last up to 1 hour. Participants will recline in a chair. Sensors to measure the activity of the heart will be placed on their chest. Different sensors will be placed on two fingers and one big toe. A device to measure blood pressure will be placed on one arm. While wearing the sensors, participants will undergo 3 tests: They will be asked to breathe slowly for 2 minutes. They will be asked to solve a math problem. They will immerse one hand or foot into an ice bath for up to 2 minutes. Each test will be followed by a 5-minute recovery period. Participants may elect to return for up to 3 more visits during the following week.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 26, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

April 19, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2025

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 8, 2025

Completed
Last Updated

February 27, 2026

Status Verified

February 24, 2026

Enrollment Period

2.3 years

First QC Date

September 22, 2022

Last Update Submit

February 25, 2026

Conditions

Keywords

Optical TechniquePulse Transit TimePearson Correlation CoefficientSpg WaveformSignal QualityNatural History

Outcome Measures

Primary Outcomes (1)

  • Use of sPTT as a marker for blood pressure.

    To examine the use of sPTT as a marker for blood pressure.

    1 year

Secondary Outcomes (1)

  • use of sPTT in comparison to pPTT

    1 year

Study Arms (1)

1

Male or female, aged 18 or greater in good general health as evidenced by medical history

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male or female, aged 18 or greater in good general health as evidenced by medical history

You may qualify if:

  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Male or female, aged 18 or greater.
  • In good general health as evidenced by medical history and physical.

You may not qualify if:

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Any active cardiovascular or pulmonary disorders or use of vasoactive medications.
  • History of aneurysm or stroke.
  • Pregnant by history.
  • History of fainting or seizures.
  • An open cut, sore, or bone fracture on or near the hands or feet.
  • Known retinopathy, intraocular lens implantation, or glaucoma.
  • Any other condition that in the opinion of the investigator would place the participant at unacceptable risk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Links

Study Officials

  • Bruce J Tromberg

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2022

First Posted

September 26, 2022

Study Start

April 19, 2023

Primary Completion

August 5, 2025

Study Completion

August 8, 2025

Last Updated

February 27, 2026

Record last verified: 2026-02-24

Locations